Robert J. Mulroy, President and CEO at MERRIMACK PHARMACEUTICALS INC (MACK), sold 150,000 shares at $10.94 ($1.6M) on 2015-02-20, disclosed to the SEC on 2015-02-20.
Scheduled sale ($1.6M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MACK | SELL | 2014-12-09 | $2.0M | — | Filing → |
| MACK | BUY | 2014-05-07 | $32K | — | Filing → |
| MACK | BUY | 2013-12-05 | $146K | — | Filing → |